img

Global Female Contraceptive Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Female Contraceptive Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Female contraceptives, also known as female birth control are methods of preventing pregnancy that primarily involve the female physiology.
The global Female Contraceptive market size was US$ 18390 million in 2024 and is forecast to a readjusted size of US$ 22120 million by 2034 with a CAGR of 2.6% during the forecast period 2024-2034.
Female contraceptive devices account for major shares of the contraceptive pills market throughout the forecast period. The increasing adoption of female contraceptive devices will drive the growth of this product segment in the female contraceptive market.
In terms of sales (consumption) side, this report focuses on the sales of Female Contraceptive by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Female Contraceptive market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Female Contraceptive market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Merck
Pfizer
Allergan
Bayer
Okamoto Industries
Reckitt Benckiser
Lupin Pharmaceuticals
Foundation Consumer Healthcare
Teva Pharmaceuticals
Ansell
Ferring Pharmaceuticals
Fuji Latex
Janssen Pharmaceuticals
By Type
Female Contraceptive Devices
Female Contraceptive Drugs
By Application
Online Stores
Retail Outlets
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Female Contraceptive in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Female Contraceptive manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Female Contraceptive sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Female Contraceptive Definition
1.2 Market by Type
1.2.1 Global Female Contraceptive Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Female Contraceptive Devices
1.2.3 Female Contraceptive Drugs
1.3 Market Segment by Application
1.3.1 Global Female Contraceptive Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Online Stores
1.3.3 Retail Outlets
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Female Contraceptive Sales
2.1 Global Female Contraceptive Revenue Estimates and Forecasts 2018-2034
2.2 Global Female Contraceptive Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Female Contraceptive Revenue by Region
2.3.1 Global Female Contraceptive Revenue by Region (2018-2023)
2.3.2 Global Female Contraceptive Revenue by Region (2024-2034)
2.4 Global Female Contraceptive Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Female Contraceptive Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Female Contraceptive Sales Quantity by Region
2.6.1 Global Female Contraceptive Sales Quantity by Region (2018-2023)
2.6.2 Global Female Contraceptive Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Female Contraceptive Sales Quantity by Manufacturers
3.1.1 Global Female Contraceptive Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Female Contraceptive Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Female Contraceptive Sales in 2024
3.2 Global Female Contraceptive Revenue by Manufacturers
3.2.1 Global Female Contraceptive Revenue by Manufacturers (2018-2023)
3.2.2 Global Female Contraceptive Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Female Contraceptive Revenue in 2024
3.3 Global Female Contraceptive Sales Price by Manufacturers
3.4 Global Key Players of Female Contraceptive, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Female Contraceptive Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Female Contraceptive, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Female Contraceptive, Product Offered and Application
3.8 Global Key Manufacturers of Female Contraceptive, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Female Contraceptive Sales Quantity by Type
4.1.1 Global Female Contraceptive Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Female Contraceptive Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Female Contraceptive Sales Quantity Market Share by Type (2018-2034)
4.2 Global Female Contraceptive Revenue by Type
4.2.1 Global Female Contraceptive Historical Revenue by Type (2018-2023)
4.2.2 Global Female Contraceptive Forecasted Revenue by Type (2024-2034)
4.2.3 Global Female Contraceptive Revenue Market Share by Type (2018-2034)
4.3 Global Female Contraceptive Price by Type
4.3.1 Global Female Contraceptive Price by Type (2018-2023)
4.3.2 Global Female Contraceptive Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Female Contraceptive Sales Quantity by Application
5.1.1 Global Female Contraceptive Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Female Contraceptive Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Female Contraceptive Sales Quantity Market Share by Application (2018-2034)
5.2 Global Female Contraceptive Revenue by Application
5.2.1 Global Female Contraceptive Historical Revenue by Application (2018-2023)
5.2.2 Global Female Contraceptive Forecasted Revenue by Application (2024-2034)
5.2.3 Global Female Contraceptive Revenue Market Share by Application (2018-2034)
5.3 Global Female Contraceptive Price by Application
5.3.1 Global Female Contraceptive Price by Application (2018-2023)
5.3.2 Global Female Contraceptive Price Forecast by Application (2024-2034)
6 North America
6.1 North America Female Contraceptive Sales by Company
6.1.1 North America Female Contraceptive Revenue by Company (2018-2023)
6.1.2 North America Female Contraceptive Sales Quantity by Company (2018-2023)
6.2 North America Female Contraceptive Market Size by Type
6.2.1 North America Female Contraceptive Sales Quantity by Type (2018-2034)
6.2.2 North America Female Contraceptive Revenue by Type (2018-2034)
6.3 North America Female Contraceptive Market Size by Application
6.3.1 North America Female Contraceptive Sales Quantity by Application (2018-2034)
6.3.2 North America Female Contraceptive Revenue by Application (2018-2034)
6.4 North America Female Contraceptive Market Size by Country
6.4.1 North America Female Contraceptive Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Female Contraceptive Revenue by Country (2018-2034)
6.4.3 North America Female Contraceptive Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Female Contraceptive Sales by Company
7.1.1 Europe Female Contraceptive Sales Quantity by Company (2018-2023)
7.1.2 Europe Female Contraceptive Revenue by Company (2018-2023)
7.2 Europe Female Contraceptive Market Size by Type
7.2.1 Europe Female Contraceptive Sales Quantity by Type (2018-2034)
7.2.2 Europe Female Contraceptive Revenue by Type (2018-2034)
7.3 Europe Female Contraceptive Market Size by Application
7.3.1 Europe Female Contraceptive Sales Quantity by Application (2018-2034)
7.3.2 Europe Female Contraceptive Revenue by Application (2018-2034)
7.4 Europe Female Contraceptive Market Size by Country
7.4.1 Europe Female Contraceptive Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Female Contraceptive Revenue by Country (2018-2034)
7.4.3 Europe Female Contraceptive Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Female Contraceptive Sales by Company
8.1.1 China Female Contraceptive Sales Quantity by Company (2018-2023)
8.1.2 China Female Contraceptive Revenue by Company (2018-2023)
8.2 China Female Contraceptive Market Size by Type
8.2.1 China Female Contraceptive Sales Quantity by Type (2018-2034)
8.2.2 China Female Contraceptive Revenue by Type (2018-2034)
8.3 China Female Contraceptive Market Size by Application
8.3.1 China Female Contraceptive Sales Quantity by Application (2018-2034)
8.3.2 China Female Contraceptive Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Female Contraceptive Sales by Company
9.1.1 APAC Female Contraceptive Sales Quantity by Company (2018-2023)
9.1.2 APAC Female Contraceptive Revenue by Company (2018-2023)
9.2 APAC Female Contraceptive Market Size by Type
9.2.1 APAC Female Contraceptive Sales Quantity by Type (2018-2034)
9.2.2 APAC Female Contraceptive Revenue by Type (2018-2034)
9.3 APAC Female Contraceptive Market Size by Application
9.3.1 APAC Female Contraceptive Sales Quantity by Application (2018-2034)
9.3.2 APAC Female Contraceptive Revenue by Application (2018-2034)
9.4 APAC Female Contraceptive Market Size by Region
9.4.1 APAC Female Contraceptive Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Female Contraceptive Revenue by Region (2018-2034)
9.4.3 APAC Female Contraceptive Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Female Contraceptive Sales by Company
10.1.1 Middle East, Africa and Latin America Female Contraceptive Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Female Contraceptive Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Female Contraceptive Market Size by Type
10.2.1 Middle East, Africa and Latin America Female Contraceptive Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Female Contraceptive Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Female Contraceptive Market Size by Application
10.3.1 Middle East, Africa and Latin America Female Contraceptive Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Female Contraceptive Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Female Contraceptive Market Size by Country
10.4.1 Middle East, Africa and Latin America Female Contraceptive Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Female Contraceptive Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Female Contraceptive Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Female Contraceptive Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Merck Female Contraceptive Products and Services
11.1.5 Merck Female Contraceptive SWOT Analysis
11.1.6 Merck Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Female Contraceptive Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Pfizer Female Contraceptive Products and Services
11.2.5 Pfizer Female Contraceptive SWOT Analysis
11.2.6 Pfizer Recent Developments
11.3 Allergan
11.3.1 Allergan Company Information
11.3.2 Allergan Overview
11.3.3 Allergan Female Contraceptive Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Allergan Female Contraceptive Products and Services
11.3.5 Allergan Female Contraceptive SWOT Analysis
11.3.6 Allergan Recent Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Overview
11.4.3 Bayer Female Contraceptive Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Bayer Female Contraceptive Products and Services
11.4.5 Bayer Female Contraceptive SWOT Analysis
11.4.6 Bayer Recent Developments
11.5 Okamoto Industries
11.5.1 Okamoto Industries Company Information
11.5.2 Okamoto Industries Overview
11.5.3 Okamoto Industries Female Contraceptive Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Okamoto Industries Female Contraceptive Products and Services
11.5.5 Okamoto Industries Female Contraceptive SWOT Analysis
11.5.6 Okamoto Industries Recent Developments
11.6 Reckitt Benckiser
11.6.1 Reckitt Benckiser Company Information
11.6.2 Reckitt Benckiser Overview
11.6.3 Reckitt Benckiser Female Contraceptive Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Reckitt Benckiser Female Contraceptive Products and Services
11.6.5 Reckitt Benckiser Female Contraceptive SWOT Analysis
11.6.6 Reckitt Benckiser Recent Developments
11.7 Lupin Pharmaceuticals
11.7.1 Lupin Pharmaceuticals Company Information
11.7.2 Lupin Pharmaceuticals Overview
11.7.3 Lupin Pharmaceuticals Female Contraceptive Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Lupin Pharmaceuticals Female Contraceptive Products and Services
11.7.5 Lupin Pharmaceuticals Female Contraceptive SWOT Analysis
11.7.6 Lupin Pharmaceuticals Recent Developments
11.8 Foundation Consumer Healthcare
11.8.1 Foundation Consumer Healthcare Company Information
11.8.2 Foundation Consumer Healthcare Overview
11.8.3 Foundation Consumer Healthcare Female Contraceptive Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Foundation Consumer Healthcare Female Contraceptive Products and Services
11.8.5 Foundation Consumer Healthcare Female Contraceptive SWOT Analysis
11.8.6 Foundation Consumer Healthcare Recent Developments
11.9 Teva Pharmaceuticals
11.9.1 Teva Pharmaceuticals Company Information
11.9.2 Teva Pharmaceuticals Overview
11.9.3 Teva Pharmaceuticals Female Contraceptive Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Teva Pharmaceuticals Female Contraceptive Products and Services
11.9.5 Teva Pharmaceuticals Female Contraceptive SWOT Analysis
11.9.6 Teva Pharmaceuticals Recent Developments
11.10 Ansell
11.10.1 Ansell Company Information
11.10.2 Ansell Overview
11.10.3 Ansell Female Contraceptive Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Ansell Female Contraceptive Products and Services
11.10.5 Ansell Female Contraceptive SWOT Analysis
11.10.6 Ansell Recent Developments
11.11 Ferring Pharmaceuticals
11.11.1 Ferring Pharmaceuticals Company Information
11.11.2 Ferring Pharmaceuticals Overview
11.11.3 Ferring Pharmaceuticals Female Contraceptive Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Ferring Pharmaceuticals Female Contraceptive Products and Services
11.11.5 Ferring Pharmaceuticals Recent Developments
11.12 Fuji Latex
11.12.1 Fuji Latex Company Information
11.12.2 Fuji Latex Overview
11.12.3 Fuji Latex Female Contraceptive Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 Fuji Latex Female Contraceptive Products and Services
11.12.5 Fuji Latex Recent Developments
11.13 Janssen Pharmaceuticals
11.13.1 Janssen Pharmaceuticals Company Information
11.13.2 Janssen Pharmaceuticals Overview
11.13.3 Janssen Pharmaceuticals Female Contraceptive Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.13.4 Janssen Pharmaceuticals Female Contraceptive Products and Services
11.13.5 Janssen Pharmaceuticals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Female Contraceptive Value Chain Analysis
12.2 Female Contraceptive Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Female Contraceptive Production Mode & Process
12.4 Female Contraceptive Sales and Marketing
12.4.1 Female Contraceptive Sales Channels
12.4.2 Female Contraceptive Distributors
12.5 Female Contraceptive Customers
13 Market Dynamics
13.1 Female Contraceptive Industry Trends
13.2 Female Contraceptive Market Drivers
13.3 Female Contraceptive Market Challenges
13.4 Female Contraceptive Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Female Contraceptive Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Female Contraceptive Devices
Table 3. Major Manufacturers of Female Contraceptive Drugs
Table 4. Global Female Contraceptive Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 5. Global Female Contraceptive Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Female Contraceptive Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Female Contraceptive Revenue Market Share by Region (2018-2023)
Table 8. Global Female Contraceptive Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Female Contraceptive Revenue Market Share by Region (2024-2034)
Table 10. Global Female Contraceptive Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 11. Global Female Contraceptive Sales by Region (2018-2023) & (K Units)
Table 12. Global Female Contraceptive Sales Market Share by Region (2018-2023)
Table 13. Global Female Contraceptive Sales by Region (2024-2034) & (K Units)
Table 14. Global Female Contraceptive Sales Market Share by Region (2024-2034)
Table 15. Global Female Contraceptive Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 16. Global Female Contraceptive Sales Quantity Share by Manufacturers (2018-2023)
Table 17. Global Female Contraceptive Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Female Contraceptive Revenue Share by Manufacturers (2018-2023)
Table 19. Global Female Contraceptive Price by Manufacturers 2018-2023 (USD/Unit)
Table 20. Global Key Players of Female Contraceptive, Industry Ranking, 2021 VS 2024
Table 21. Global Female Contraceptive Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Female Contraceptive by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Contraceptive as of 2024)
Table 23. Global Key Manufacturers of Female Contraceptive, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Female Contraceptive, Product Offered and Application
Table 25. Global Key Manufacturers of Female Contraceptive, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Female Contraceptive Sales Quantity by Type (2018-2023) & (K Units)
Table 28. Global Female Contraceptive Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Female Contraceptive Sales Quantity Share by Type (2018-2023)
Table 30. Global Female Contraceptive Sales Quantity Share by Type (2024-2034)
Table 31. Global Female Contraceptive Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Female Contraceptive Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Female Contraceptive Revenue Share by Type (2018-2023)
Table 34. Global Female Contraceptive Revenue Share by Type (2024-2034)
Table 35. Female Contraceptive Price by Type (2018-2023) & (USD/Unit)
Table 36. Global Female Contraceptive Price Forecast by Type (2024-2034) & (USD/Unit)
Table 37. Global Female Contraceptive Sales Quantity by Application (2018-2023) & (K Units)
Table 38. Global Female Contraceptive Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Female Contraceptive Sales Quantity Share by Application (2018-2023)
Table 40. Global Female Contraceptive Sales Quantity Share by Application (2024-2034)
Table 41. Global Female Contraceptive Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Female Contraceptive Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Female Contraceptive Revenue Share by Application (2018-2023)
Table 44. Global Female Contraceptive Revenue Share by Application (2024-2034)
Table 45. Female Contraceptive Price by Application (2018-2023) & (USD/Unit)
Table 46. Global Female Contraceptive Price Forecast by Application (2024-2034) & (USD/Unit)
Table 47. North America Female Contraceptive Revenue by Company (2018-2023) & (US$ Million)
Table 48. North America Female Contraceptive Sales Quantity by Company (2018-2023) & (K Units)
Table 49. North America Female Contraceptive Sales Quantity by Type (2018-2023) & (K Units)
Table 50. North America Female Contraceptive Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Female Contraceptive Revenue by Type (2018-2023) & (US$ Million)
Table 52. North America Female Contraceptive Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Female Contraceptive Sales Quantity by Application (2018-2023) & (K Units)
Table 54. North America Female Contraceptive Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Female Contraceptive Revenue by Application (2018-2023) & (US$ Million)
Table 56. North America Female Contraceptive Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Female Contraceptive Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 58. North America Female Contraceptive Revenue by Country (2018-2023) & (US$ Million)
Table 59. North America Female Contraceptive Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Female Contraceptive Sales Quantity by Country (2018-2023) & (K Units)
Table 61. North America Female Contraceptive Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Female Contraceptive Sales Quantity by Company (2018-2023) & (K Units)
Table 63. Europe Female Contraceptive Revenue by Company (2018-2023) & (US$ Million)
Table 64. Europe Female Contraceptive Sales Quantity by Type (2018-2023) & (K Units)
Table 65. Europe Female Contraceptive Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Female Contraceptive Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Female Contraceptive Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Female Contraceptive Sales Quantity by Application (2018-2023) & (K Units)
Table 69. Europe Female Contraceptive Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Female Contraceptive Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Female Contraceptive Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Female Contraceptive Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 73. Europe Female Contraceptive Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Female Contraceptive Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Female Contraceptive Sales Quantity by Country (2018-2023) & (K Units)
Table 76. Europe Female Contraceptive Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Female Contraceptive Sales Quantity by Company (2018-2023) & (K Units)
Table 78. China Female Contraceptive Revenue by Company (2018-2023) & (US$ Million)
Table 79. China Female Contraceptive Sales Quantity by Type (2018-2023) & (K Units)
Table 80. China Female Contraceptive Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Female Contraceptive Revenue by Type (2018-2023) & (US$ Million)
Table 82. China Female Contraceptive Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Female Contraceptive Sales Quantity by Application (2018-2023) & (K Units)
Table 84. China Female Contraceptive Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Female Contraceptive Revenue by Application (2018-2023) & (US$ Million)
Table 86. China Female Contraceptive Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Female Contraceptive Sales Quantity by Company (2018-2023) & (K Units)
Table 88. APAC Female Contraceptive Revenue by Company (2018-2023) & (US$ Million)
Table 89. APAC Female Contraceptive Sales Quantity by Type (2018-2023) & (K Units)
Table 90. APAC Female Contraceptive Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Female Contraceptive Revenue by Type (2018-2023) & (US$ Million)
Table 92. APAC Female Contraceptive Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Female Contraceptive Sales Quantity by Application (2018-2023) & (K Units)
Table 94. APAC Female Contraceptive Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Female Contraceptive Revenue by Application (2018-2023) & (US$ Million)
Table 96. APAC Female Contraceptive Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Female Contraceptive Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 98. APAC Female Contraceptive Revenue by Region (2018-2023) & (US$ Million)
Table 99. APAC Female Contraceptive Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Female Contraceptive Sales Quantity by Region (2018-2023) & (K Units)
Table 101. APAC Female Contraceptive Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Female Contraceptive Sales Quantity by Company (2018-2023) & (K Units)
Table 103. Middle East, Africa and Latin America Female Contraceptive Revenue by Company (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Female Contraceptive Sales Quantity by Type (2018-2023) & (K Units)
Table 105. Middle East, Africa and Latin America Female Contraceptive Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Female Contraceptive Revenue by Type (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Female Contraceptive Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Female Contraceptive Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Middle East, Africa and Latin America Female Contraceptive Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Female Contraceptive Revenue by Application (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Female Contraceptive Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Female Contraceptive Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Female Contraceptive Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Female Contraceptive Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Female Contraceptive Sales Quantity by Country (2018-2023) & (K Units)
Table 116. Middle East, Africa and Latin America Female Contraceptive Sales Quantity by Country (2024-2034) & (K Units)
Table 117. Merck Company Information
Table 118. Merck Description and Overview
Table 119. Merck Female Contraceptive Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 120. Merck Female Contraceptive Product and Services
Table 121. Merck Female Contraceptive SWOT Analysis
Table 122. Merck Recent Developments
Table 123. Pfizer Company Information
Table 124. Pfizer Description and Overview
Table 125. Pfizer Female Contraceptive Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 126. Pfizer Female Contraceptive Product and Services
Table 127. Pfizer Female Contraceptive SWOT Analysis
Table 128. Pfizer Recent Developments
Table 129. Allergan Company Information
Table 130. Allergan Description and Overview
Table 131. Allergan Female Contraceptive Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 132. Allergan Female Contraceptive Product and Services
Table 133. Allergan Female Contraceptive SWOT Analysis
Table 134. Allergan Recent Developments
Table 135. Bayer Company Information
Table 136. Bayer Description and Overview
Table 137. Bayer Female Contraceptive Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 138. Bayer Female Contraceptive Product and Services
Table 139. Bayer Female Contraceptive SWOT Analysis
Table 140. Bayer Recent Developments
Table 141. Okamoto Industries Company Information
Table 142. Okamoto Industries Description and Overview
Table 143. Okamoto Industries Female Contraceptive Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 144. Okamoto Industries Female Contraceptive Product and Services
Table 145. Okamoto Industries Female Contraceptive SWOT Analysis
Table 146. Okamoto Industries Recent Developments
Table 147. Reckitt Benckiser Company Information
Table 148. Reckitt Benckiser Description and Overview
Table 149. Reckitt Benckiser Female Contraceptive Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 150. Reckitt Benckiser Female Contraceptive Product and Services
Table 151. Reckitt Benckiser Female Contraceptive SWOT Analysis
Table 152. Reckitt Benckiser Recent Developments
Table 153. Lupin Pharmaceuticals Company Information
Table 154. Lupin Pharmaceuticals Description and Overview
Table 155. Lupin Pharmaceuticals Female Contraceptive Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 156. Lupin Pharmaceuticals Female Contraceptive Product and Services
Table 157. Lupin Pharmaceuticals Female Contraceptive SWOT Analysis
Table 158. Lupin Pharmaceuticals Recent Developments
Table 159. Foundation Consumer Healthcare Company Information
Table 160. Foundation Consumer Healthcare Description and Overview
Table 161. Foundation Consumer Healthcare Female Contraceptive Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 162. Foundation Consumer Healthcare Female Contraceptive Product and Services
Table 163. Foundation Consumer Healthcare Female Contraceptive SWOT Analysis
Table 164. Foundation Consumer Healthcare Recent Developments
Table 165. Teva Pharmaceuticals Company Information
Table 166. Teva Pharmaceuticals Description and Overview
Table 167. Teva Pharmaceuticals Female Contraceptive Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 168. Teva Pharmaceuticals Female Contraceptive Product and Services
Table 169. Teva Pharmaceuticals Female Contraceptive SWOT Analysis
Table 170. Teva Pharmaceuticals Recent Developments
Table 171. Ansell Company Information
Table 172. Ansell Description and Overview
Table 173. Ansell Female Contraceptive Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 174. Ansell Female Contraceptive Product and Services
Table 175. Ansell Female Contraceptive SWOT Analysis
Table 176. Ansell Recent Developments
Table 177. Ferring Pharmaceuticals Company Information
Table 178. Ferring Pharmaceuticals Description and Overview
Table 179. Ferring Pharmaceuticals Female Contraceptive Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 180. Ferring Pharmaceuticals Female Contraceptive Product and Services
Table 181. Ferring Pharmaceuticals Recent Developments
Table 182. Fuji Latex Company Information
Table 183. Fuji Latex Description and Overview
Table 184. Fuji Latex Female Contraceptive Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 185. Fuji Latex Female Contraceptive Product and Services
Table 186. Fuji Latex Recent Developments
Table 187. Janssen Pharmaceuticals Company Information
Table 188. Janssen Pharmaceuticals Description and Overview
Table 189. Janssen Pharmaceuticals Female Contraceptive Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 190. Janssen Pharmaceuticals Female Contraceptive Product and Services
Table 191. Janssen Pharmaceuticals Recent Developments
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Female Contraceptive Distributors List
Table 195. Female Contraceptive Customers List
Table 196. Female Contraceptive Market Trends
Table 197. Female Contraceptive Market Drivers
Table 198. Female Contraceptive Market Challenges
Table 199. Female Contraceptive Market Restraints
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Female Contraceptive Product Picture
Figure 2. Global Female Contraceptive Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Female Contraceptive Market Share by Type in 2024 & 2034
Figure 4. Female Contraceptive Devices Product Picture
Figure 5. Female Contraceptive Drugs Product Picture
Figure 6. Global Female Contraceptive Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 7. Global Female Contraceptive Market Share by Application in 2024 & 2034
Figure 8. Online Stores
Figure 9. Retail Outlets
Figure 10. Female Contraceptive Report Years Considered
Figure 11. Global Female Contraceptive Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Female Contraceptive Revenue 2018-2034 (US$ Million)
Figure 13. Global Female Contraceptive Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 14. Global Female Contraceptive Sales Quantity 2018-2034 (K Units)
Figure 15. Global Female Contraceptive Sales Quantity Market Share by Region (2018-2023)
Figure 16. Global Female Contraceptive Sales Quantity Market Share by Region (2024-2034)
Figure 17. North America Female Contraceptive Sales Quantity YoY (2018-2034) & (K Units)
Figure 18. North America Female Contraceptive Revenue YoY (2018-2034) & (US$ Million)
Figure 19. Europe Female Contraceptive Sales Quantity YoY (2018-2034) & (K Units)
Figure 20. Europe Female Contraceptive Revenue YoY (2018-2034) & (US$ Million)
Figure 21. China Female Contraceptive Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. China Female Contraceptive Revenue YoY (2018-2034) & (US$ Million)
Figure 23. APAC Female Contraceptive Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. APAC Female Contraceptive Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Female Contraceptive Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. Middle East, Africa and Latin America Female Contraceptive Revenue YoY (2018-2034) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Female Contraceptive Sales Quantity in 2024
Figure 28. The Top 10 and Top 5 Players Market Share by Female Contraceptive Revenue in 2024
Figure 29. Female Contraceptive Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 30. Global Female Contraceptive Sales Quantity Market Share by Type (2018-2034)
Figure 31. Global Female Contraceptive Revenue Market Share by Type (2018-2034)
Figure 32. Global Female Contraceptive Sales Quantity Market Share by Application (2018-2034)
Figure 33. Global Female Contraceptive Revenue Market Share by Application (2018-2034)
Figure 34. North America Female Contraceptive Revenue Market Share by Company in 2024
Figure 35. North America Female Contraceptive Sales Quantity Market Share by Company in 2024
Figure 36. North America Female Contraceptive Sales Quantity Market Share by Type (2018-2034)
Figure 37. North America Female Contraceptive Revenue Market Share by Type (2018-2034)
Figure 38. North America Female Contraceptive Sales Quantity Market Share by Application (2018-2034)
Figure 39. North America Female Contraceptive Revenue Market Share by Application (2018-2034)
Figure 40. North America Female Contraceptive Revenue Share by Country (2018-2034)
Figure 41. North America Female Contraceptive Sales Quantity Share by Country (2018-2034)
Figure 42. U.S. Female Contraceptive Revenue (2018-2034) & (US$ Million)
Figure 43. Canada Female Contraceptive Revenue (2018-2034) & (US$ Million)
Figure 44. Europe Female Contraceptive Sales Quantity Market Share by Company in 2024
Figure 45. Europe Female Contraceptive Revenue Market Share by Company in 2024
Figure 46. Europe Female Contraceptive Sales Quantity Market Share by Type (2018-2034)
Figure 47. Europe Female Contraceptive Revenue Market Share by Type (2018-2034)
Figure 48. Europe Female Contraceptive Sales Quantity Market Share by Application (2018-2034)
Figure 49. Europe Female Contraceptive Revenue Market Share by Application (2018-2034)
Figure 50. Europe Female Contraceptive Revenue Share by Country (2018-2034)
Figure 51. Europe Female Contraceptive Sales Quantity Share by Country (2018-2034)
Figure 52. Germany Female Contraceptive Revenue (2018-2034) & (US$ Million)
Figure 53. France Female Contraceptive Revenue (2018-2034) & (US$ Million)
Figure 54. U.K. Female Contraceptive Revenue (2018-2034) & (US$ Million)
Figure 55. Italy Female Contraceptive Revenue (2018-2034) & (US$ Million)
Figure 56. Russia Female Contraceptive Revenue (2018-2034) & (US$ Million)
Figure 57. China Female Contraceptive Sales Quantity Market Share by Company in 2024
Figure 58. China Female Contraceptive Revenue Market Share by Company in 2024
Figure 59. China Female Contraceptive Sales Quantity Market Share by Type (2018-2034)
Figure 60. China Female Contraceptive Revenue Market Share by Type (2018-2034)
Figure 61. China Female Contraceptive Sales Quantity Market Share by Application (2018-2034)
Figure 62. China Female Contraceptive Revenue Market Share by Application (2018-2034)
Figure 63. APAC Female Contraceptive Sales Quantity Market Share by Company in 2024
Figure 64. APAC Female Contraceptive Revenue Market Share by Company in 2024
Figure 65. APAC Female Contraceptive Sales Quantity Market Share by Type (2018-2034)
Figure 66. APAC Female Contraceptive Revenue Market Share by Type (2018-2034)
Figure 67. APAC Female Contraceptive Sales Quantity Market Share by Application (2018-2034)
Figure 68. APAC Female Contraceptive Revenue Market Share by Application (2018-2034)
Figure 69. APAC Female Contraceptive Revenue Share by Region (2018-2034)
Figure 70. APAC Female Contraceptive Sales Quantity Share by Region (2018-2034)
Figure 71. Japan Female Contraceptive Revenue (2018-2034) & (US$ Million)
Figure 72. South Korea Female Contraceptive Revenue (2018-2034) & (US$ Million)
Figure 73. China Taiwan Female Contraceptive Revenue (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Female Contraceptive Revenue (2018-2034) & (US$ Million)
Figure 75. India Female Contraceptive Revenue (2018-2034) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Female Contraceptive Sales Quantity Market Share by Company in 2024
Figure 77. Middle East, Africa and Latin America Female Contraceptive Revenue Market Share by Company in 2024
Figure 78. Middle East, Africa and Latin America Female Contraceptive Sales Quantity Market Share by Type (2018-2034)
Figure 79. Middle East, Africa and Latin America Female Contraceptive Revenue Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Female Contraceptive Sales Quantity Market Share by Application (2018-2034)
Figure 81. Middle East, Africa and Latin America Female Contraceptive Revenue Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Female Contraceptive Sales Quantity Share by Country (2018-2034)
Figure 83. Middle East, Africa and Latin America Female Contraceptive Revenue Share by Country (2018-2034)
Figure 84. Brazil Female Contraceptive Revenue (2018-2034) & (US$ Million)
Figure 85. Mexico Female Contraceptive Revenue (2018-2034) & (US$ Million)
Figure 86. Turkey Female Contraceptive Revenue (2018-2034) & (US$ Million)
Figure 87. Israel Female Contraceptive Revenue (2018-2034) & (US$ Million)
Figure 88. GCC Countries Female Contraceptive Revenue (2018-2034) & (US$ Million)
Figure 89. Female Contraceptive Value Chain
Figure 90. Female Contraceptive Production Process
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed